Showing 4611-4620 of 23276 results for "".
Nemluvio Shows Efficacy in AD
https://reachmd.com/series/dermwire-tv/nemluvio-shows-efficacy-in-ad/36134/In this episode of DermwireTV, Nemluvio (nemolizumab) showed efficacy in atopic dermatitis in recent studies; strontium cream helps manage pruritus in hidradenitis suppurativa (HS); and Lisa Swanson and Peter Lio get viewers up to date on dupilumab’s effectiveness at halting atopic march.Journal Club: Dupilumab and Atopic March
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedDigital CBT and Pulmonary Fibrosis: Addressing Anxiety and Quality of Life
https://reachmd.com/programs/clinicians-roundtable/digital-cbt-and-pulmonary-fibrosis-addressing-anxiety-and-quality-of-life/35656/Patients with pulmonary fibrosis often face anxiety and emotional distress that go unadressed during their care. Given this unmet need, a digital cognitive behavioral therapy (CBT) platform was designed to support emotional wellbeing alonside medical treatment. Mr. Ryan Quigley sits down with Drs. JSeborrheic Dermatitis Approaches and Stopping Biologic Treatment for Atopic Dermatitis
https://reachmd.com/conferences/scale-2025/seborrheic-dermatitis-approaches-and-stopping-biologic-treatment-for-atopic-dermatitis/35896/Naiem T. Issa, MD, PhD, talks at Music City SCALE 2025 about how to approach seborrheic dermatitis, as well as what happens to atopic dermatitis patients after ending biologic treatments.Advances in Hair Loss Treatments
https://reachmd.com/conferences/scale-2025/advances-in-hair-loss-treatments/35899/Marc R. Avram, MD, talks at Music City SCALE 2025 about hair loss and advances in platelet-rich plasma (PRP), lasers, and transplantation.Pediatric Responses to SARS-CoV-2: What We’ve Learned So Far
https://reachmd.com/programs/clinicians-roundtable/pediatric-responses-to-sars-cov-2-what-weve-learned-so-far/35464/Since the start of the COVID-19 pandemic, our understanding of how children respond to the virus has grown significantly. Join Dr. Diego Hijano as he breaks down these advancements, including how pediatric immune responses and conditions like multisystemic inflammatory syndrome can inform the way weAdvancing Cancer Care: Key Considerations for Subcutaneous Immunotherapies
https://reachmd.com/programs/project-oncology/advancing-cancer-care-key-considerations-for-subcutaneous-immunotherapies/32995/Subcutaneous cancer immunotherapies may offer a faster, more resource-efficient alternative to intravenous administration, improving patient convenience and accessibility while maintaining efficacy. However, careful monitoring for immunotherapy-related toxicities remains essential. Joining Dr. CharlMATV NEWS: Genesis: Innovations in Aesthetic Regenerative Medicine Registration Opens And More
https://reachmd.com/programs/modern-aesthetics/MATV-NEWS-Genesis-Innovations-Aesthetic-Regenerative-Medicine-Registration-Opens-More/33233/In this week's episode of MATV News, an update on the 2025 Genesis: Innovations in Aesthetic Regenerative Medicine Meeting; the FDA approves a new neurotoxin for the glabellar lines; Closing the health care gender gap; and Martha Stewart was the keynote speaker for 2025 AAD Annual Meeting.Dr. Anderson on New Tech That ‘Could be Revolutionary’ at Maui Derm
https://reachmd.com/conferences/maui-derm-hawaii-2025/dr-anderson-on-new-tech-that-could-be-revolutionary-at-maui-derm/32921/In-vivo microscopy that will change how dermatologists practice and potentially revolutionary drug delivery systems were among the technologies highlighted by R. Rox Anderson, MD, PhD, during “Innovation in Dermatology 2025: A Look Into the Future of Dermatology” at the Maui Derm Hawaii 2025 meetingMaui Derm Panel: GLP-1 Agonists Can Help Psoriasis Patients
https://reachmd.com/conferences/maui-derm-hawaii-2025/maui-derm-panel-glp-1-agonists-can-help-psoriasis-patients/32917/Only 11% of Maui Derm 2025 audience members polled said they were comfortable prescribing weight-loss drugs, and 49% said they were not at all—but they should be, according to the presenters of “Psoriasis Update 2025” at the conference in Maui, Hawaii.